+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Nerve Repair and Regeneration Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • PDF Icon

    Report

  • 400 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 5989301
The global nerve repair and regeneration market attained a value of USD 9.33 Billion in 2024 driven by the rising prevalence of neurodegenerative disorders with technological advancements across the globe. It is expected to grow at a CAGR of 15.10% in the forecast period of 2025-2034 and attain a value of USD 38.07 Billion by 2034.

Nerve Repair and Regeneration Market Overview

Neural repair and regeneration help in healing and restoring damaged nerves in the brain and spinal cord. They work with different types of nerve injuries related to trauma, neurodegenerative disorders, and specific surgeries. These injuries may affect the quality of life of a person adversely, often resulting in paralysis or loss of sensation. The market is witnessing an increased integration of technical advancements to bring improved solutions to patients. Preference for minimally invasive procedures, focus on personalised treatments and expanding use of stem cell therapies are amongst the major market trends.

Nerve Repair and Regeneration Market Growth Drivers

Increasing Prevalence of Neurodegenerative Disorders Boosts Market Growth

One of the most significant factors contributing to the market growth for nerve repair is the growing cases of nerve disorders and damage. According to the World Health Organization, Parkinson’s disease affects approximately more than 10 million people all over the world while Alzheimer’s disease affects 55 million people. With the increasing incidence of these diseases, there is a high demand for better and improved treatments. Hence, the need for products like nerve grafts, nerve conduits, and other products that aid in the healing and care of affected nerves is on the rise.

Surge in Research Initiatives and Product Launches to Meet Rising Nerve Repair and Regeneration Market Demand

Researchers are developing new products such as nerve conduits that assist in nerve regrowth. Such technological advancements are aimed at helping many patients regain their nerve function. In May 2024, researchers at the University of Birmingham created a red light therapy for enhancing nerve growth and function to repair spinal cord injuries. With the use of 660nm light, the treatment decreased scarring and revived feeling and mobility in preclinical models.

Moreover, the launch of new products that offer advanced products to the users are expected to fuel market growth in the coming years. For instance, In June 2024, Axogen, Inc. introduced Avive+ Soft Tissue Matrix, a novel product created for safeguarding soft tissue during the recovery of peripheral nerves. The resorbable amniotic membrane allograft acts as a temporary barrier to aid in the healing process of nerve injuries such as carpal and cubital tunnel syndromes. Avive+ complies with FDA guidelines for tissue products, broadening Axogen’s range of nerve protection solutions.

Nerve Repair and Regeneration Market Trends

Use of Minimally Invasive Procedures

Doctors are increasingly using less invasive procedures, so as to reduce patient pain and shorten hospital stays. The trend for minimally invasive procedures is expected to continue as people tend to choose lower-risk and less painful treatments.

Rising Use of Biomaterials to Boost the Nerve Repair and Regeneration Market Value

Biomaterials are more commonly used to promote tissue healing and address nerve regeneration. They provide support for the regeneration of nerves that have been damaged and further enhancements in the application of biomaterials is expected to elevate the market size significantly in the forecast period.

Growing Use of Stem Cell Therapies

Stem cell therapies are growing in usage for nerve regeneration with more tests being conducted. These therapies assist in replacing injured neurons and are expected to have larger application prospects in the forecast period.

Focus on Personalized Treatments

A significant trend in the market involves developing customized therapies for repairing nerves, with doctors tailoring treatments to match an individual's specific biology. Personalised treatments are expected to become increasingly popular as improvements in medical technology enable more personalized approaches.

Nerve Repair and Regeneration Market Segmentation

Market Breakup by Product

  • Neurostimulation and Neuromodulation Devices
  • Internal Neurostimulation Device
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Sacral Nerve Stimulation
  • Gastric Electrical Stimulation
  • External Neurostimulation Device
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Biomaterials
  • Nerve Conduit
  • Nerve Protector
  • Nerve Connector
  • Others

Market Breakup by Technology

  • Stem Cell Therapy
  • Gene Therapy
  • 3D Bioprinting
  • Electrotherapy

Market Breakup by Application

  • Neurostimulation and Neuromodulation Surgeries
  • Direct Nerve Repair
  • Nerve Grafting
  • Stem Cell Therapy
  • Others

Market Breakup by End User

  • Hospitals
  • Specialized Clinics
  • Research and Academic Institutes
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Nerve Repair and Regeneration Market Share

Market Segmentation Based on End User Set to Witness Substantial Growth

Based on end users, the market is divided into hospitals, specialized clinics, research and academic institutes, and others. Among these, hospitals are expected to dominate the market due to their well-developed infrastructure and well-trained healthcare professionals to deal with complicated operational procedures.

Nerve Repair and Regeneration Market Analysis by Region

Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Among these, North America is expected to dominate the market due to the high incidence of neurodegenerative disorders, an existing and developed network of healthcare providers, and increased concern for R&D. The market share can also be attributed to suitable reimbursement policies in this region.

On the other hand, the Asia Pacific is expected to become another prominent market for nerve repair and regeneration due to growing concerns around the healthcare budget, the increasing incidence of neurological disorders, and the growing availability of innovative treatment options in the region.

Leading Players in the Nerve Repair and Regeneration Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:

Medtronic plc

Medtronic plc was founded in 1949 and is based in Dublin. It is one of the largest medical device companies in the world. Medtronic also produces neurostimulation devices that utilize electrical impulses to promote nerve healing and can be employed in managing chronic pain and nerve damage.

AxoGen, Inc.

Based in Alachua, Florida, and was established in 2002. The primary focus is on products intended for repairing nerve damage, such as nerve conduits and nerve shields. AxoGen has made a name for itself as a pioneer in addressing peripheral nerve injuries.

Stryker Corporation

Stryker Corporation, founded in 1941, is headquartered in Kalamazoo, Michigan. It produces instruments and equipment used in nerve surgeries such as neurosurgery and neurovascular instruments. Nerve repair is among the most critical areas that utilize Stryker’s products, making it a vital market player.

Boston Scientific Corporation

Founded in 1979 and headquartered in Marlborough, Massachusetts, the company specializes in the production of medical devices. It provides neurostimulation products for treating Chronic Intractable Pain and promoting nerve regrowth. These devices are employed for pain and taken to the functional level for patients with severe nerve injuries.

Other companies include Nerve Repair and Regeneration, Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, Collagen Matrix Inc., Medovex Corporation, and Axogen Corporation.

Key Questions Answered in the Nerve Repair and Regeneration Market

  • What was the global nerve repair and regeneration market value in 2024?
  • What is the global nerve repair and regeneration market forecast outlook for 2025-2034?
  • What are the regional markets covered in the report?
  • What is the market segmentation based on the product?
  • What is the market breakup based on technology?
  • What is the market segmentation based on the application?
  • What is the market breakup based on the end user?
  • What are the major factors aiding the global nerve repair and regeneration market demand?
  • What are the market's major drivers, opportunities, and restraints?
  • Which regional market is expected to lead the market share in the forecast period?
  • Which country is expected to experience expedited growth during the forecast period?
  • What are the major global nerve repair and regeneration market trends?
  • How does the rise in the geriatric population impact the market size?
  • Who are the key players involved in the nerve repair and regeneration market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
  • What role does 3D bioprinting play in the future of nerve regeneration technologies?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nerve Repair and Regeneration Market Overview
3.1 Global Nerve Repair and Regeneration Market Historical Value (2018-2024)
3.2 Global Nerve Repair and Regeneration Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Nerve Repair and Regeneration Market Landscape*
5.1 Global Nerve Repair and Regeneration: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Nerve Repair and Regeneration: Product Landscape
5.2.1 Analysis by Product
5.2.2 Analysis by Modality
6 Global Nerve Repair and Regeneration Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Nerve Repair and Regeneration Market Segmentation (218-2034)
7.1 Global Nerve Repair and Regeneration Market (2018-2034) by Product
7.1.1 Market Overview
7.1.2 Neurostimulation and Neuromodulation Devices
7.1.3 Internal Neurostimulation Device
7.1.3.1 Spinal Cord Stimulation
7.1.3.2 Deep Brain Stimulation
7.1.3.3 Vagus Nerve Stimulation
7.1.3.4 Sacral Nerve Stimulation
7.1.3.5 Gastric Electrical Stimulation
7.1.4 External Neurostimulation Device
7.1.4.1 Transcutaneous Electrical Nerve Stimulation
7.1.4.2 Transcranial Magnetic Stimulation
7.1.5 Biomaterials
7.1.5.1 Nerve Conduit
7.1.5.2 Nerve Protector
7.1.5.3 Nerve Connector
7.1.5.4 Others
7.2 Global Nerve Repair and Regeneration Market (2018-2034) by Technology
7.2.1 Market Overview
7.2.2 Stem Cell Therapy
7.2.3 Gene Therapy
7.2.4 3D Bioprinting
7.2.5 Electrotherapy
7.3 Global Nerve Repair and Regeneration Market (2018-2034) by Application
7.3.1 Market Overview
7.3.2 Neurostimulation and Neuromodulation Surgeries
7.3.3 Direct Nerve Repair
7.3.4 Nerve Grafting
7.3.5 Stem Cell Therapy
7.3.6 Others
7.4 Global Nerve Repair and Regeneration Market (2018-2034) by End User
7.4.1 Market Overview
7.4.2 Hospitals
7.4.3 Specialized Clinics
7.4.4 Research and Academic Institutes
7.4.5 Others
7.5 Global Nerve Repair and Regeneration Market (2018-2034) by Region
7.5.1 Market Overview
7.5.2 North America
7.5.3 Europe
7.5.4 Asia Pacific
7.5.5 Latin America
7.5.6 Middle East and Africa
8 North America Nerve Repair and Regeneration Market (218-2034)
8.1 North America Nerve Repair and Regeneration Market (2018-2034) by Product
8.1.1 Market Overview
8.1.2 Neurostimulation and Neuromodulation Devices
8.1.3 Internal Neurostimulation Device
8.1.3.1 Spinal Cord Stimulation
8.1.3.2 Deep Brain Stimulation
8.1.3.3 Vagus Nerve Stimulation
8.1.3.4 Sacral Nerve Stimulation
8.1.3.5 Gastric Electrical Stimulation
8.1.4 External Neurostimulation Device
8.1.4.1 Transcutaneous Electrical Nerve Stimulation
8.1.4.2 Transcranial Magnetic Stimulation
8.1.5 Biomaterials
8.1.5.1 Nerve Conduit
8.1.5.2 Nerve Protector
8.1.5.3 Nerve Connector
8.1.5.4 Others
8.2 North America Nerve Repair and Regeneration Market (2018-2034) by Technology
8.2.1 Market Overview
8.2.2 Stem Cell Therapy
8.2.3 Gene Therapy
8.2.4 3D Bioprinting
8.2.5 Electrotherapy
8.3 North America Nerve Repair and Regeneration Market (2018-2034) by Application
8.3.1 Market Overview
8.3.2 Neurostimulation and Neuromodulation Surgeries
8.3.3 Direct Nerve Repair
8.3.4 Nerve Grafting
8.3.5 Stem Cell Therapy
8.3.6 Others
8.4 North America Nerve Repair and Regeneration Market (2018-2034) by End User
8.4.1 Market Overview
8.4.2 Hospitals
8.4.3 Specialized Clinics
8.4.4 Research and Academic Institutes
8.4.5 Others
8.5 North America Nerve Repair and Regeneration Market (2018-2034) by Country
8.5.1 United States of America
8.5.2 Canada
9 Europe Nerve Repair and Regeneration Market (218-2034)
9.1 Europe Nerve Repair and Regeneration Market (2018-2034) by Product
9.1.1 Market Overview
9.1.2 Neurostimulation and Neuromodulation Devices
9.1.3 Internal Neurostimulation Device
9.1.3.1 Spinal Cord Stimulation
9.1.3.2 Deep Brain Stimulation
9.1.3.3 Vagus Nerve Stimulation
9.1.3.4 Sacral Nerve Stimulation
9.1.3.5 Gastric Electrical Stimulation
9.1.4 External Neurostimulation Device
9.1.4.1 Transcutaneous Electrical Nerve Stimulation
9.1.4.2 Transcranial Magnetic Stimulation
9.1.5 Biomaterials
9.1.5.1 Nerve Conduit
9.1.5.2 Nerve Protector
9.1.5.3 Nerve Connector
9.1.5.4 Others
9.2 Europe Nerve Repair and Regeneration Market (2018-2034) by Technology
9.2.1 Market Overview
9.2.2 Stem Cell Therapy
9.2.3 Gene Therapy
9.2.4 3D Bioprinting
9.2.5 Electrotherapy
9.3 Europe Nerve Repair and Regeneration Market (2018-2034) by Application
9.3.1 Market Overview
9.3.2 Neurostimulation and Neuromodulation Surgeries
9.3.3 Direct Nerve Repair
9.3.4 Nerve Grafting
9.3.5 Stem Cell Therapy
9.3.6 Others
9.4 Europe Nerve Repair and Regeneration Market (2018-2034) by End User
9.4.1 Market Overview
9.4.2 Hospitals
9.4.3 Specialized Clinics
9.4.4 Research and Academic Institutes
9.4.5 Others
9.5 Europe Nerve Repair and Regeneration Market (2018-2034) by Country
9.5.1 United Kingdom
9.5.2 Germany
9.5.3 France
9.5.4 Italy
9.5.5 Others
10 Asia Pacific Nerve Repair and Regeneration Market (218-2034)
10.1 Asia Pacific Nerve Repair and Regeneration Market (2018-2034) by Product
10.1.1 Market Overview
10.1.2 Neurostimulation and Neuromodulation Devices
10.1.3 Internal Neurostimulation Device
10.1.3.1 Spinal Cord Stimulation
10.1.3.2 Deep Brain Stimulation
10.1.3.3 Vagus Nerve Stimulation
10.1.3.4 Sacral Nerve Stimulation
10.1.3.5 Gastric Electrical Stimulation
10.1.4 External Neurostimulation Device
10.1.4.1 Transcutaneous Electrical Nerve Stimulation
10.1.4.2 Transcranial Magnetic Stimulation
10.1.5 Biomaterials
10.1.5.1 Nerve Conduit
10.1.5.2 Nerve Protector
10.1.5.3 Nerve Connector
10.1.5.4 Others
10.2 Asia Pacific Nerve Repair and Regeneration Market (2018-2034) by Technology
10.2.1 Market Overview
10.2.2 Stem Cell Therapy
10.2.3 Gene Therapy
10.2.4 3D Bioprinting
10.2.5 Electrotherapy
10.3 Asia Pacific Nerve Repair and Regeneration Market (2018-2034) by Application
10.3.1 Market Overview
10.3.2 Neurostimulation and Neuromodulation Surgeries
10.3.3 Direct Nerve Repair
10.3.4 Nerve Grafting
10.3.5 Stem Cell Therapy
10.3.6 Others
10.4 Asia Pacific Nerve Repair and Regeneration Market (2018-2034) by End User
10.4.1 Market Overview
10.4.2 Hospitals
10.4.3 Specialized Clinics
10.4.4 Research and Academic Institutes
10.4.5 Others
10.5 Asia Pacific Nerve Repair and Regeneration Market (2018-2034) by Country
10.5.1 China
10.5.2 Japan
10.5.3 India
10.5.4 ASEAN
10.5.5 Australia
10.5.6 Others
11 Latin America Nerve Repair and Regeneration Market (218-2034)
11.1 Latin America Nerve Repair and Regeneration Market (2018-2034) by Product
11.1.1 Market Overview
11.1.2 Neurostimulation and Neuromodulation Devices
11.1.3 Internal Neurostimulation Device
11.1.3.1 Spinal Cord Stimulation
11.1.3.2 Deep Brain Stimulation
11.1.3.3 Vagus Nerve Stimulation
11.1.3.4 Sacral Nerve Stimulation
11.1.3.5 Gastric Electrical Stimulation
11.1.4 External Neurostimulation Device
11.1.4.1 Transcutaneous Electrical Nerve Stimulation
11.1.4.2 Transcranial Magnetic Stimulation
11.1.5 Biomaterials
11.1.5.1 Nerve Conduit
11.1.5.2 Nerve Protector
11.1.5.3 Nerve Connector
11.1.5.4 Others
11.2 Latin America Nerve Repair and Regeneration Market (2018-2034) by Technology
11.2.1 Market Overview
11.2.2 Stem Cell Therapy
11.2.3 Gene Therapy
11.2.4 3D Bioprinting
11.2.5 Electrotherapy
11.3 Latin America Nerve Repair and Regeneration Market (2018-2034) by Application
11.3.1 Market Overview
11.3.2 Neurostimulation and Neuromodulation Surgeries
11.3.3 Direct Nerve Repair
11.3.4 Nerve Grafting
11.3.5 Stem Cell Therapy
11.3.6 Others
11.4 Latin America Nerve Repair and Regeneration Market (2018-2034) by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Specialized Clinics
11.4.4 Research and Academic Institutes
11.4.5 Others
11.5 Latin America Nerve Repair and Regeneration Market (2018-2034) by Country
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Mexico
11.5.4 Others
12 Middle East and Africa Nerve Repair and Regeneration Market (218-2034)
12.1 Middle East and Africa Nerve Repair and Regeneration Market (2018-2034) by Product
12.1.1 Market Overview
12.1.2 Neurostimulation and Neuromodulation Devices
12.1.3 Internal Neurostimulation Device
12.1.3.1 Spinal Cord Stimulation
12.1.3.2 Deep Brain Stimulation
12.1.3.3 Vagus Nerve Stimulation
12.1.3.4 Sacral Nerve Stimulation
12.1.3.5 Gastric Electrical Stimulation
12.1.4 External Neurostimulation Device
12.1.4.1 Transcutaneous Electrical Nerve Stimulation
12.1.4.2 Transcranial Magnetic Stimulation
12.1.5 Biomaterials
12.1.5.1 Nerve Conduit
12.1.5.2 Nerve Protector
12.1.5.3 Nerve Connector
12.1.5.4 Others
12.2 Middle East and Africa Nerve Repair and Regeneration Market (2018-2034) by Technology
12.2.1 Market Overview
12.2.2 Stem Cell Therapy
12.2.3 Gene Therapy
12.2.4 3D Bioprinting
12.2.5 Electrotherapy
12.3 Middle East and Africa Nerve Repair and Regeneration Market (2018-2034) by Application
12.3.1 Market Overview
12.3.2 Neurostimulation and Neuromodulation Surgeries
12.3.3 Direct Nerve Repair
12.3.4 Nerve Grafting
12.3.5 Stem Cell Therapy
12.3.6 Others
12.4 Middle East and Africa Nerve Repair and Regeneration Market (2018-2034) by End User
12.4.1 Market Overview
12.4.2 Hospitals
12.4.3 Specialized Clinics
12.4.4 Research and Academic Institutes
12.4.5 Others
12.5 Middle East and Africa Nerve Repair and Regeneration Market (2018-2034) by Country
12.5.1 Saudi Arabia
12.5.2 United Arab Emirates
12.5.3 Nigeria
12.5.4 South Africa
12.5.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Grants Analysis
15.1 Analysis by Year
15.2 Analysis by Amount Awarded
15.3 Analysis by Issuing Authority
15.4 Analysis by Grant Application
15.5 Analysis by Funding Institute
15.6 Analysis by NIH Departments
15.7 Analysis by Recipient Organization
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Strategic Initiatives
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership and Collaborations
17.3 Analysis by Joint Ventures
17.4 Analysis by Leading Players
17.5 Analysis by Geography
18 Supplier Landscape
18.1 Market Share Analysis, By Region (Top 5 Companies)
18.1.1 Market Share Analysis: Global
18.1.2 Market Share Analysis: North America
18.1.3 Market Share Analysis: Europe
18.1.4 Market Share Analysis: Asia Pacific
18.1.5 Market Share Analysis: Others
18.2 Medtronic plc
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Company News and Development
18.2.5 Certifications
18.3 AxoGen, Inc.
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Company News and Development
18.3.5 Certifications
18.4 Stryker Corporation
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Company News and Development
18.4.5 Certifications
18.5 Boston Scientific Corporation
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Company News and Development
18.5.5 Certifications
18.6 Nerve Repair and Regeneration
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Company News and Development
18.6.5 Certifications
18.7 Zimmer Biomet Holdings, Inc.
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Company News and Development
18.7.5 Certifications
18.8 Integra LifeSciences Holdings Corporation
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Company News and Development
18.8.5 Certifications
18.9 Collagen Matrix Inc.
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Company News and Development
18.9.5 Certifications
18.10 Medovex Corporation
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Company News and Development
18.10.5 Certifications
18.11 Axogen Corporation
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Company News and Development
18.11.5 Certifications
19 Global Nerve Repair and Regeneration Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • Medtronic plc
  • AxoGen, Inc.
  • Stryker Corporation
  • Boston Scientific Corporation

Table Information